BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15069547)

  • 1. Tyrosine phosphorylation of NOS3 in a breast cancer cell line and Src-transformed cells.
    Takenouchi Y; Oo ML; Senga T; Watanabe Y; Machida K; Miyazaki K; Nimura Y; Hamaguchi M
    Oncol Rep; 2004 May; 11(5):1059-62. PubMed ID: 15069547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27).
    Wang XB; Lee H; Capozza F; Marmon S; Sotgia F; Brooks JW; Campos-Gonzalez R; Lisanti MP
    Biochemistry; 2004 Nov; 43(43):13694-706. PubMed ID: 15504032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
    Golubovskaya VM; Virnig C; Cance WG
    Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
    Tan M; Li P; Sun M; Yin G; Yu D
    Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src-mediated phosphorylation regulates subcellular distribution and activity of human inducible nitric oxide synthase.
    Hausel P; Latado H; Courjault-Gautier F; Felley-Bosco E
    Oncogene; 2006 Jan; 25(2):198-206. PubMed ID: 16116474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
    Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
    Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
    Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
    J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide mediates the survival action of IGF-1 and insulin in pancreatic beta cells.
    Cahuana GM; Tejedo JR; Hmadcha A; Ramírez R; Cuesta AL; Soria B; Martin F; Bedoya FJ
    Cell Signal; 2008 Feb; 20(2):301-10. PubMed ID: 18023142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation of phospholipase D1 by v-Src does not per se result in activation.
    Ho WT; Xie Z; Zhao ZJ; Exton JH
    Cell Signal; 2005 Jun; 17(6):691-9. PubMed ID: 15722193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Src activation by ErbB2 leads to attachment-independent growth of human breast epithelial cells.
    Sheffield LG
    Biochem Biophys Res Commun; 1998 Sep; 250(1):27-31. PubMed ID: 9735325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death.
    Lluis JM; Buricchi F; Chiarugi P; Morales A; Fernandez-Checa JC
    Cancer Res; 2007 Aug; 67(15):7368-77. PubMed ID: 17671207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of hTAFII68 (NTD)-mediated transactivation by v-Src.
    Lee HJ; Kim S; Pelletier J; Kim J
    FEBS Lett; 2004 Apr; 564(1-2):188-98. PubMed ID: 15094065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRC-induced disassembly of adherens junctions requires localized phosphorylation and degradation of the rac activator tiam1.
    Woodcock SA; Rooney C; Liontos M; Connolly Y; Zoumpourlis V; Whetton AD; Gorgoulis VG; Malliri A
    Mol Cell; 2009 Mar; 33(5):639-53. PubMed ID: 19285946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E; Montiel M
    J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for multiple Src binding sites on the alpha1c L-type Ca2+ channel and their roles in activity regulation.
    Dubuis E; Rockliffe N; Hussain M; Boyett M; Wray D; Gawler D
    Cardiovasc Res; 2006 Feb; 69(2):391-401. PubMed ID: 16352297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical rescue of a mutant enzyme in living cells.
    Qiao Y; Molina H; Pandey A; Zhang J; Cole PA
    Science; 2006 Mar; 311(5765):1293-7. PubMed ID: 16513984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.